Since the discovery of anticancer efficacy of titanocene dichloride (Cp<sub>2</sub>TiCl<sub>2</sub>, TDC) by Koepf in 1979, the study of antitumor properties of metallocene complexes is one o...Since the discovery of anticancer efficacy of titanocene dichloride (Cp<sub>2</sub>TiCl<sub>2</sub>, TDC) by Koepf in 1979, the study of antitumor properties of metallocene complexes is one of the most active subjects after that of cisplatin in this field. Being highly active against展开更多
基金Project supported by the National Natural Science Foundation of Chinaby the Youth Science Foundation of Shanxi Province.
文摘Since the discovery of anticancer efficacy of titanocene dichloride (Cp<sub>2</sub>TiCl<sub>2</sub>, TDC) by Koepf in 1979, the study of antitumor properties of metallocene complexes is one of the most active subjects after that of cisplatin in this field. Being highly active against